| Diclofenac |
20020740 |
Voltaren Retard, Prolonged release tablet, 100 mg, -, Pack: 10 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
1.96 |
0.39 |
2.35 |
7% |
0.14 |
2.1 |
0.42 |
2.52 |
20% |
0.39 |
2.49 |
0.5 |
2.99 |
НСР-1846/25.11.2013 |
09.12.2013 |
09.12.2013 |
корекц. Решение НСР-2474/22.01.2014 |
|
Активен |
7273 |
| Diclofenac |
1044/19.11.2007 г. |
VOLTAREN RETARD 100, Prolonged release tablet, 100 mg, -, Pack: 10 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Германия |
4.13 |
0.83 |
4.96 |
7% |
0.29 |
4.42 |
0.88 |
5.3 |
20% |
0.83 |
5.25 |
1.05 |
6.3 |
КЦ-530/
19,02,2009 г. |
05.03.2009 |
05.03.2009 |
|
|
Неактивен |
7273 |
| Diclofenac |
1153/03.12.2007 г. |
VOLTFAST, Powder for oral solution, 50 mg, -, Pack: 30 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
1.72 |
0.34 |
2.06 |
7% |
0.12 |
1.84 |
0.37 |
2.21 |
20% |
0.34 |
2.18 |
0.44 |
2.62 |
КЦ-270/05.11.2008 г.; НСР-16302/27.07.2018 |
22.11.2008 |
02.09.2018 |
|
|
Заличен |
7268 |
| Diclofenac |
1153/03.12.2007 г. |
VOLTFAST, Powder for oral solution, 50 mg, -, Pack: 30 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
1.72 |
0.34 |
2.06 |
7% |
0.12 |
1.84 |
0.37 |
2.21 |
20% |
0.34 |
2.18 |
0.44 |
2.62 |
КЦ-270/
05,11,2008 г. |
22.11.2008 |
22.11.2008 |
|
|
Неактивен |
7268 |
| Dimenhydrinate |
20040461 |
Vomacur, suppositories, 40 mg, -, Pack: 10 |
Hexal AG, Германия |
Salutas Pharma GmbH, Германия |
9.84 |
1.97 |
11.81 |
7% |
0.69 |
10.53 |
2.11 |
12.64 |
20% |
1.97 |
12.5 |
2.5 |
15 |
НСР-5809/12.03.2015. |
26.03.2015 |
26.03.2015 |
|
|
Активен |
9031 |
| Dimenhydrinate |
20040461 |
Vomacur, suppositories, 40 mg, -, Pack: 5 |
Hexal AG, Германия |
Salutas Pharma GmbH, Германия Rubiepharm Arzneimittel Gmb Германия |
3.91 |
0.78 |
4.69 |
7% |
0.27 |
4.18 |
0.84 |
5.02 |
20% |
0.78 |
4.96 |
0.99 |
5.95 |
НСР-1410/10.10.2013 |
25.10.2013 |
25.10.2013 |
|
|
Активен |
8495 |
| Valsartan |
20120305 |
Walzera, Film coated tablet, 40 mg, -, Pack: 30 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Šlandrova ulica 4, 1231 Ljubljana, Črnuče, Словения |
5.87 |
1.17 |
7.04 |
7% |
0.41 |
6.28 |
1.26 |
7.54 |
20% |
1.17 |
7.45 |
1.49 |
8.94 |
КЦPP-1751/04.12.2012 г.; НСР-16540/17.08.2018 |
20.12.2012 |
02.09.2018 |
|
|
Заличен |
8180 |
| Valsartan |
20120305 |
Walzera, Film coated tablet, 40 mg, -, Pack: 30 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Šlandrova ulica 4, 1231 Ljubljana, Črnuče, Словения |
5.87 |
1.17 |
7.04 |
7% |
0.41 |
6.28 |
1.26 |
7.54 |
20% |
1.17 |
7.45 |
1.49 |
8.94 |
КЦPP-1751/04.12.2012 г. |
20.12.2012 |
20.12.2012 |
|
|
Неактивен |
8180 |
| Coagulation factor VIII, Factor von Willebrand |
20110734 |
Wilate, Powder and solvent for solution for injection, 1000 IU coagulation factor VIII и 1000 IU human von Willebrand factor, -, Pack: 1 vial |
Octapharma (IP) SPRL, Белгия |
Octapharma Pharmazeutika Produktionsges, m.b.H. Oberlaaerstr.235 A-1100 Vienna, Австрия |
772.47 |
154.49 |
926.96 |
4% |
10 |
782.47 |
156.49 |
938.96 |
16% |
25 |
807.47 |
161.49 |
968.96 |
НСР-6059/16.04.2015. |
16.05.2015 |
02.02.2019 |
Промяна на обстоятелства НСР-17681/02.01.2019 |
|
Активен |
3419 |
| Coagulation factor VIII, Factor von Willebrand |
20110734 |
Wilate, Powder and solvent for solution for injection, 1000 IU coagulation factor VIII и 1000 IU human von Willebrand factor, -, Pack: 1 vial |
Octapharma (IP) Ltd., Обединено Кралство |
Octapharma Pharmazeutika Produktionsges, m.b.H. Oberlaaerstr.235 A-1100 Vienna, Австрия |
772.47 |
154.49 |
926.96 |
4% |
10 |
782.47 |
156.49 |
938.96 |
16% |
25 |
807.47 |
161.49 |
968.96 |
НСР-6059/16.04.2015. |
16.05.2015 |
16.05.2015 |
|
|
Неактивен |
3419 |
| Crizotinib |
EU/1/12/793/001 |
Xalkori, Capsule, hard, 200 mg, -, Pack: 60 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Manufacturing Deutschland GmbH, Германия |
9892.2 |
1978.44 |
11870.64 |
4% |
10 |
9902.2 |
1980.44 |
11882.64 |
16% |
25 |
9927.2 |
1985.44 |
11912.64 |
НСР-4356/05.08.2014 |
02.09.2014 |
02.01.2019 |
Промяна на обстоятелства НСР-17457/13.12.2018 |
|
Активен |
2410 |
| Crizotinib |
EU/1/12/793/001 |
Xalkori, Capsule, hard, 200 mg, -, Pack: 60 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
9892.2 |
1978.44 |
11870.64 |
4% |
10 |
9902.2 |
1980.44 |
11882.64 |
16% |
25 |
9927.2 |
1985.44 |
11912.64 |
НСР-4356/05.08.2014 |
02.09.2014 |
02.09.2014 |
|
|
Неактивен |
2410 |
| Mercaptopurine |
EU/1/11/727/001 |
Xaluprine, Oral suspension, 20 mg/ml - 100 ml, -, Pack: 1 bottle adaptor + 2 oral syringes |
Nova Laboratories Limited, Обединено Кралство |
Nova Laboratories Limited (Обединено Кралство) |
418.55 |
83.71 |
502.26 |
4% |
10 |
428.55 |
85.71 |
514.26 |
16% |
25 |
453.55 |
90.71 |
544.26 |
НСР-9727/07.07.2016 г.; НСР-11883/06.03.017 г. |
02.08.2016 |
02.04.2017 |
|
|
Заличен |
15117 |
| Mercaptopurine |
EU/1/11/727/001 |
Xaluprine, Oral suspension, 20 mg/ml - 100 ml, -, Pack: 1 bottle adaptor + 2 oral syringes |
Nova Laboratories Limited, Обединено Кралство |
Nova Laboratories Limited (Обединено Кралство) |
418.55 |
83.71 |
502.26 |
4% |
10 |
428.55 |
85.71 |
514.26 |
16% |
25 |
453.55 |
90.71 |
544.26 |
НСР-9727/07.07.2016 г. |
02.08.2016 |
02.08.2016 |
|
|
Неактивен |
15117 |
| Alprazolam |
20020165 |
XANAX, Tablet, 0,5, mg, Pack: 100 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Localita Marino del Tronto, Ascoli, 63100 Piceno (AP), Italy |
4.21 |
0.84 |
5.05 |
7% |
0.29 |
4.5 |
0.9 |
5.4 |
20% |
0.84 |
5.34 |
1.07 |
6.41 |
НСР-3791/16.06.2014 |
16.07.2014 |
02.02.2019 |
Промяна на обстоятелства НСР-11027/24.11.2016; НСР-17753/17.01.2019 |
|
Активен |
2891 |
| Alprazolam |
20020165 |
XANAX, Tablet, 0,5, mg, Pack: 100 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Localita Marino del Tronto, Ascoli, 63100 Piceno (AP), Italy |
4.21 |
0.84 |
5.05 |
7% |
0.29 |
4.5 |
0.9 |
5.4 |
20% |
0.84 |
5.34 |
1.07 |
6.41 |
НСР-3791/16.06.2014 |
16.07.2014 |
02.01.2017 |
Промяна на обстоятелства НСР-11027/24.11.2016 |
|
Неактивен |
2891 |
| Alprazolam |
20020166 |
XANAX, Tablet, 0.25, mg, Pack: 100 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Localita Marino del Tronto, 63100 Ascoli Piceno (AP), Italy |
5.1 |
1.02 |
6.12 |
7% |
0.36 |
5.46 |
1.09 |
6.55 |
20% |
1.02 |
6.48 |
1.3 |
7.78 |
НСР-15255/15.03.2018 |
02.04.2018 |
02.02.2019 |
Промяна на обстоятелства НСР-17753/17.01.2019 |
|
Активен |
1641 |
| Alprazolam |
20020166 |
XANAX, Tablet, 0.25, mg, Pack: 100 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Localita Marino del Tronto, 63100 Ascoli Piceno (AP), Italy |
5.1 |
1.02 |
6.12 |
7% |
0.36 |
5.46 |
1.09 |
6.55 |
20% |
1.02 |
6.48 |
1.3 |
7.78 |
НСР-15255/15.03.2018 |
02.04.2018 |
02.04.2018 |
|
|
Неактивен |
1641 |
| Alprazolam |
20020165 |
XANAX, Tablet, 0.5, mg, Pack: 30 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Localita Marino del Tronto, 63100 Ascoli Piceno (AP), Italy |
2.64 |
0.53 |
3.17 |
7% |
0.18 |
2.82 |
0.56 |
3.38 |
20% |
0.53 |
3.35 |
0.67 |
4.02 |
НСР-15227/09.03.2018 |
02.04.2018 |
02.02.2019 |
Промяна на обстоятелства НСР-17753/17.01.2019 |
|
Активен |
2890 |
| Alprazolam |
20020165 |
XANAX, Tablet, 0.5, mg, Pack: 30 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Localita Marino del Tronto, 63100 Ascoli Piceno (AP), Italy |
2.64 |
0.53 |
3.17 |
7% |
0.18 |
2.82 |
0.56 |
3.38 |
20% |
0.53 |
3.35 |
0.67 |
4.02 |
НСР-15227/09.03.2018 |
02.04.2018 |
02.04.2018 |
|
|
Неактивен |
2890 |
| Alprazolam |
20020166 |
XANAX, Tablet, 0.25, mg, Pack: 30 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Localita Marino del Tronto, 63100 Ascoli Piceno (AP), Italy |
1.66 |
0.33 |
1.99 |
7% |
0.12 |
1.78 |
0.36 |
2.14 |
20% |
0.33 |
2.11 |
0.42 |
2.53 |
НСР-15228/09.03.2018 |
02.04.2018 |
02.04.2018 |
|
|
Активен |
3353 |
| Alprazolam |
II-1337/27.12.2007 |
XANAX, Tablet, 0,5 mg, -, Pack: 100 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870 Puurs, Belgium
Pharmacia Italia S.p.A., Via del Commercio, 63046 Localita Marino del Tronto, Ascoli Piceno (AP), Italy |
4.21 |
0.84 |
5.05 |
7% |
0.29 |
4.5 |
0.9 |
5.4 |
20% |
0.84 |
5.34 |
1.07 |
6.41 |
НСР-3791/16.06.2014 |
16.07.2014 |
16.07.2014 |
|
|
Неактивен |
2891 |
| Rivaroxaban |
EU/1/08/472/027 |
Xarelto, Film coated tablet, 2.5, mg, Pack: 56 |
Bayer AG, Германия |
Bayer AG, Germany; Bayer HealthCare Manufacturing Srl, Italy; Bayer Bitterfeld GmbH, Germany |
113.52 |
22.7 |
136.22 |
4% |
4.54 |
118.06 |
23.61 |
141.67 |
16% |
18.16 |
136.22 |
27.24 |
163.46 |
НСР-16129/13.07.2018 |
28.07.2018 |
02.08.2018 |
|
|
Активен |
16186 |
| Rivaroxaban |
EU/1/08/472/018 |
Xarelto, Film coated tablet, 20mg, -, Pack: 28 |
Bayer Pharma AG, Германия |
Bayer Pharma AG Leverkusen, Deutschland |
131.43 |
26.29 |
157.72 |
4% |
5.26 |
136.69 |
27.34 |
164.03 |
16% |
21.03 |
157.72 |
31.54 |
189.26 |
КЦPP-928/04.07.2012 г. |
24.07.2012 |
24.07.2012 |
корекц. решение КЦРР-1152/02.08.2012. |
|
Заличен |
3578 |
| Rivaroxaban |
EU/1/08/472/013 |
Xarelto, Film coated tablet, 15mg, -, Pack: 42 |
Bayer Pharma AG, Германия |
Bayer Pharma AG Leverkusen, Deutschland |
197.15 |
39.43 |
236.58 |
4% |
7.89 |
205.04 |
41.01 |
246.05 |
16% |
25 |
230.04 |
46.01 |
276.05 |
КЦPP-928/04.07.2012 г. |
24.07.2012 |
24.07.2012 |
корекц. решение КЦРР-1152/02.08.2012. |
|
Заличен |
2506 |